KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Non-Current Deferred Tax Liability (2020 - 2022)

GoodRx Holdings' Non-Current Deferred Tax Liability history spans 3 years, with the latest figure at $650000.0 for Q3 2022.

  • For Q3 2022, Non-Current Deferred Tax Liability changed N/A year-over-year to $650000.0; the TTM value through Sep 2022 reached $650000.0, changed N/A, while the annual FY2021 figure was $244000.0, N/A changed from the prior year.
  • Non-Current Deferred Tax Liability for Q3 2022 was $650000.0 at GoodRx Holdings, up from $455000.0 in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $1.8 million in Q3 2020 and bottomed at $244000.0 in Q4 2021.
  • The 3-year median for Non-Current Deferred Tax Liability is $455000.0 (2022), against an average of $703600.0.